Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07057414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 2, 2025 (before its estimated October 29, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints revised (18)v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized, double-blind, placebo-controlled, single-center Phase IIa clinical study.
Trial Details
NCT Number NCT07057414
Lead Sponsor Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Collaborators: Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment
Conditions
(from sponsor)		 Cadmium Exceeds the Standard
Related terms Cadmium Poisoning
Enrollment 11 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov